Feb 3, 2022 - Feb 16, 2022

Ajanta Pharma Limited Buyback (Ajanta Pharma Buyback) Detail

Incorporated in 1973, Ajanta Pharma is a multinational company based out of India engaged in the development, manufacturing, and marketing of pharmaceutical formulations.
In India, the company has a presence in high-growth specialty segments of cardiology, dermatology, ophthalmology, and pain management. Emerging markets are the major contributors to the company's branded generic business where they are present across Asia and Africa. Ajanta Pharma serves a wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products in this region.
The company's Institutional business comprises supplies to various government bodies in India and supplies of Anti-Malarial products under WHO-approved programs in Africa.
Ajanta Pharma's products are sold in over 30 countries and the company employs around 7,000 people worldwide. The company operates 7 manufacturing facilities in India, 2 of which have been successfully approved by the US FDA. The company's R&D center has a team of over 750 scientists.

Ajanta Pharma Buyback Detail

Issue PeriodFeb 3, 2022 - Feb 16, 2022
Security NameAjanta Pharma Limited
Issue TypeTender Offer
Issue Size (Shares)1,120,000.00
Issue Size (Amount)₹285.60 Crores
Buyback Price₹2550 per share
Face Value₹2 per share
Listing AtBSE, NSE

Ajanta Pharma Buyback Issue Timetable

Record DateJan 14, 2022
Offer Opens OnFeb 3, 2022
Last Date for receipt of Tender FormsFeb 16, 2022
Offer Closes OnFeb 16, 2022
Finalisation of Buyback AcceptanceFeb 24, 2022
Last Date for settlment of bidsFeb 25, 2022
Last Date for Extinguishment of SharesMar 4, 2022

Buyback Ratio

Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 30 Equity Shares out of every 151 shares held on the record date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 91 shares held on the record date.

Company Financials

Summary of financial Information Consolidated)
Particulars For the year/period ended (Rs. in Crores)
  30-Sep-21 31-Mar-21 31-Mar-20
Total Income 1,694.96 2,915.67 2,680.06
Profit After Tax 369.69 653.87 467.70
Net Worth 3,358.90 2,995.63 2,598.87
Reserves and Surplus 3,341.51 2,978.24 2,581.33

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 2,239.10 2,015.80 2,136.74
Oct-2021 2,366.30 2,053.65 2,213.24
Sep-2021 2,340.00 2,112.70 2,199.31

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 2,239.10 2,000.00 2,137.44
Oct-2021 2,365.80 2,053.65 2,213.37
Sep-2021 2,330.00 2,110.00 2,201.05

Necessity of the Issue

The Buyback aims to :
i) Distribute surplus funds to shareholders and thereby enhance their overall return.
ii) Improve financial ratios like Earnings per share (EPS), Return on assets (ROA) and Return on Equity (ROE).

Ajanta Pharma Buyback Documents

Ajanta Pharma Buyback Rating

Rating:Rated 3.0 stars
Vote Here ...

Ajanta Pharma Buyback Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Ajanta Pharma Limited
‘Ajanta House’, 98 Govt Industrial Area, Chark
Kandivli (West),
Mumbai - 400 067, Maharashtra, India

Phone: +91 22 6606 1000
Email: investorgrievance@ajantapharma.com
Website: http://www.ajantapharma.com/

Ajanta Pharma Buyback Registrar

  1. Link Intime India Private Ltd
       Link Intime India Private Ltd
       C 101, 247 Park, L.B.S.Marg,
       Vikhroli (West), Mumbai - 400083

    Phone: +91-22-4918 6270
    Email: ajantapharma.buyback2022@linkintime.co.in
    Website: https://linkintime.co.in/

Ajanta Pharma Buyback Manager

Lead Manager(s)

  1. Vivro Financial Services Private Limited

Registered Broker

  1. Pravin Ratilal Share and Stock Brokers Limited
    Email: info@prssb.com

Find Ajanta Pharma Buyback Latest Update

Ajanta Pharma Buyback FAQs

The Ajanta Pharma Buyback opens on Feb 3, 2022, and closes on Feb 16, 2022.

The Ajanta Pharma Buyback last day to buy is not available as of now.

The Ajanta Pharma Buyback is a Tender Offer.

Ajanta Pharma Buyback Schedule

Buyback Opening DateFeb 3, 2022
Buyback Closing DateFeb 16, 2022
Last Date for receipt of Tender FormsFeb 16, 2022
Finalisation of Buyback AcceptanceFeb 24, 2022
Last Date for settlment of bidsFeb 25, 2022
Last Date for Extinguishment of SharesMar 4, 2022

The Ajanta Pharma Buyback is being offered at Rs ₹2550 per share per equity share.

Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 30 Equity Shares out of every 151 shares held on the record date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 91 shares held on the record date.

The record date for the Ajanta Pharma Buyback is Jan 14, 2022.

The issue size of Ajanta Pharma Buyback is of 1,120,000.00 equity shares at ₹2550 per share aggregating upto ₹285.60 Crores.

The Buyback aims to :
i) Distribute surplus funds to shareholders and thereby enhance their overall return.
ii) Improve financial ratios like Earnings per share (EPS), Return on assets (ROA) and Return on Equity (ROE).

All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.

The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.

The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.

The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.

The Ajanta Pharma Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


20. CSS     Link|Mar 2, 2022 7:37:39 PM
The buy back amount is not credited into my account still for the Ajanta Pharma.
Can anyone provide details when will this happen.
20.1. ANURAG SARAF     Link|Mar 4, 2022 9:00:08 AM
check you bank details in your demat account. if bank details are wrong amount credited in trading account.
19. Suneel Padavala     Link|Feb 24, 2022 12:14:40 PM
Today will we get to know about AR details? Also when will stock be removed from Demat account and money will be credited?
19.2. DuckkyDuck     Link|Feb 25, 2022 11:35:17 AM
AR is nearly 54.8% for retail reserved(less than 2lac) category. My 45 out of 82 shares got accepted.
All shares will be debited, and un-accepted shares will be credited back to account.
As i am an already invested long term investor in Ajanta pharma, i am again buying my accepted shares from market. I have bought in range of 1900-2200. Will buy more in coming days at current price in range 1750-1800. This way my total avg price will be near 2000. So its like i sold by 45 shares at 2550 and bought is at 2000.
At the start, my holding was 102 share.
My profit from BB is 45*550=2450.
At the end i bought those 45 shares, so my final holding remains intact with 102 shares.
19.3. Ramanand     Link|Feb 25, 2022 5:37:23 PM
Accepted 1/2, Entitlement - Zero. Debited 2/2, will be credited back 1/2. Not purchased for Buyback. But tendered.
18. ARJUN'SEYE     Link|Jan 23, 2022 7:10:08 PM
AR will be more than 60% in reserve category.....
18.5. Girish prasad     Link|Feb 24, 2022 9:34:35 PM
It is 54 % .a good judgment
18.6. ARJUN'S EYE     Link|Feb 25, 2022 12:50:04 PM
Accepted 47 shares against 85 tender shares. So, I have written ratio is 55.29%.
17. DuckkyDuck     Link|Feb 3, 2022 7:33:42 PM
Today was first day of tendering

BB issue is 11.2 lac shares. And on 1st itself nearly 38 lac shares are tendered. Making the BB issue subscribed more than 3x on 1st day.
But note that, for retail reserved category, not much shares were tendered. This high subscription is due to big investor (more than 2lac) tendering. You can see high numbers in QIB and NII.
17.4. pATILS     Link|Feb 21, 2022 9:29:15 AM

17.5. Kishen     Link|Feb 22, 2022 10:55:54 AM
Buyback closure is on 25th Feb...you can expect funds on or before 25th Feb...
16. Noor     Link|Feb 10, 2022 2:01:21 PM
@ likes @ noorul @ mravi @ksr....can anyone suggest the record date for ajanta buyback
16.3. Learntrade     Link|Feb 11, 2022 9:15:03 AM
@ksrk sir...thank u...also one more query if we have 2 shares each of mayur, FDC and kpr before record date in 5 different account...can we offer to tender during buyback....

Kpr mills under any scrutiny by NSE as during buying it is suggesting the same
16.4. KAMMA SIVA RAMA KRISHNA     Link|Feb 11, 2022 9:28:26 AM
Sometimes, even a single shall will be accepted. Try your luck.All the best.
No idea regarding your second query.
15. Zain     Link|Feb 9, 2022 11:30:51 PM
I'm first participate buyback I've angel broking Demat account anybody explain me how to participate via Angel broking
14. Ramachandram     Link|Feb 8, 2022 6:44:46 PM
Hi I'm Ram,
Having acc with zerodha & having 32.Ajanta Pharma. Pl advice if I offer for buyback will all my. 32 be accepted or how much will be accepted?

14.1. Suneel Padavala   I Like It. 1|  Link|Feb 9, 2022 11:34:51 AM
Looks AR will be around 50%, so 16 shares might be accepted. However, there are many new people (including me) participating in buyback and CMP is also around 2100Rs. So AR can come down to 40%.
13. Suneel     Link|Feb 3, 2022 8:16:57 PM

First time I'm participating in Ajanta Pharma Buyback process and I have Demat account with HDFC Securities. When we are tendering our shares in Buyback, there is a field called Facilitator. Can anyone using HDFC Securities, can you please tell what should we fill here?

Appreciate your response.

thanks, Suneel
13.1. rahulagg     Link|Feb 4, 2022 7:45:11 PM
@Suneel Sir,
You can leave that field blank.
13.2. Suneel     Link|Feb 6, 2022 7:01:57 AM
Many thanks Rahul. Appreciate your response.
12. KAMMA SIVA RAMA KRISHNA   I Like It. 1|  Link|Jan 31, 2022 8:25:33 PM
Emami is likely to consider the buyback of shares on 03/02/2022. However the previous buyback in 2020 was through the Open Offer. Let’s wait and see the outcome of the meeting of the Board of Directors. Thank you.

12.1. bscca     Link|Feb 3, 2022 1:18:20 PM
Buyback price in news is 550. Is it TENDER OFFER or through OPEN MARKET???
12.2. KAMMA SIVA RAMA KRISHNA     Link|Feb 3, 2022 2:14:04 PM
It’s through the open market. No use. Thank you.
11. DuckkyDuck   I Like It. 1|  Link|Feb 3, 2022 1:00:48 PM
Updates on emami buyback
1. Buyback from open market
2. Max price is 550 (current price ~502)
3. BB size 162 Crore Rs.

For me this not attractive as its open market. Also price difference is not much. Might consider to buy very small qty if fall to 470 level.
10. VIRAT.KOHLI   I Like It. 1|  Link|Feb 1, 2022 11:41:58 AM
9. Suneel Padavala     Link|Jan 21, 2022 5:33:47 PM
Received email from Ajantha Pharma.
I have 40 shares and ER eligibility is 7 shares.
Looks ER is 17.5%

Any idea how much could be AR? Hope you also received email.

9.6. lokes     Link|Jan 22, 2022 12:03:03 PM
@Kishen : you are not eligible else you would have got email. You can once check your spam folder also. Debit might have happened from your account by 14th.
For buybacks, never sell share until record date, its not like bonus/dividend where you can sell on ex date and still be eligible.
@suneel: yesterday ajanta pharma moved a lot and i feel on monday also it will move up due to buyback opening news. it may come near or cross your buy price.
And buyback will be profitable even if AR lesser than 50%, don't worry.
9.7. Kishen   I Like It. 1|  Link|Jan 22, 2022 12:28:25 PM
Thank you...it's a lesson learnt now...will be careful from next time...happy it didn't happen with tcs...
Thank you for your response...
8. SivaMDU     Link|Jan 14, 2022 5:48:23 PM
KSRK Sir/lokes Sir, what is the maximum number of shares for Ajanta Pharma to held as on today(14th) to be considered as retail? Is it 86? Secondly, whether this buyback is available in BSE? Because my broker told they cannot participate in NSE alone buyback. I faced problem due to this in Nucleus software.
8.2. KAMMA SIVA RAMA KRISHNA     Link|Jan 15, 2022 11:18:35 AM
On knowing the details of the site/link, the same link will be posted. Thank you.
8.3. SivaMDU     Link|Jan 18, 2022 11:54:05 AM
KSRK Sir, Thank you very much for your prompt reply and very sorry for my delayed acknowledgement.
7. IPO smart     Link|Jan 12, 2022 5:44:27 PM
Respected KSRK Sir,
Buyback size : increase to 18000 Cr.
Today I have purchased qty 43 nos of TCS for long term also. Please suggest.

7.1. KAMMA SIVA RAMA KRISHNA   I Like It. 1|  Link|Jan 12, 2022 8:31:37 PM
IPO smart ji,
On the previous occasion i.e., Dec. 2020/ Jan. 2021, the buyback price was Rs. 3000/- and the amount of the buyback was Rs. 16,000 crores whereas in the current buyback, the buyback price is Rs. 4500/- and the amount of the buyback is Rs. 18,000 crores. Hence, the current buyback is considered to be not that much attractive. AR is likely to be at least around 60% if not around 75%. For the long term also, it can be considered to be more beneficial. Thank you n all the best.
6. Rakesh Goel   I Like It. 1|  Link|Jan 12, 2022 5:51:08 PM
TCS buyback rate 4500/- via Tender.
5. IPO smart     Link|Jan 5, 2022 7:22:26 PM
There is remours of TCS buyback.
5.5. KAMMA SIVA RAMA KRISHNA   I Like It. 1|  Link|Jan 10, 2022 9:07:55 PM
IPO Smart ji,
Any price more than Rs. 4250/- will be a welcoming one. I am also hopefully looking forward for the outcome of the board meeting on 12/01. Thank you n all the best.
5.6. KAMMA SIVA RAMA KRISHNA   I Like It. 1|  Link|Jan 11, 2022 6:32:23 PM
As per the Senior Research Analyst of Zee Business the buyback price is likely to be not less than Rs.4400/-. Hopefully looking forward for the details of the buyback.
4. KAMMA SIVA RAMA KRISHNA   I Like It. 1|  Link|Jan 11, 2022 6:26:22 PM
“A meeting of the board of directors of Hinduja Global Solutions will be held on January 14, 2022, to consider and explore quantum/ timings of buy-back of equity shares of the company,” HGS said in an exchange filing. The board will also consider potential mergers & acquisition opportunities, the company said. On knowing the details of the buyback, we can take a decision. Thank you.
3. KAMMA SIVA RAMA KRISHNA     Link|Dec 31, 2021 5:18:21 PM
Today I have purchased 21 shares at the average price of Rs.2232/-. In the next phase, I will try to purchase 20 shares at around Rs. 2210/-, if available before the stipulated date. Thank you.
3.7. lokes     Link|Jan 7, 2022 1:12:22 PM
@suneel: you can get more info on buyback from here:

you will get mail after record date is over for your eligibility and shares holding on record date. you can place order for all shares as holded on record date as per mail (but it should be in your demat while placing order in buyback , so if you are selling after record date then you can buy again to tender if you wish or you can tender remaining quantity).
In buyback mail, dates will be mentioned for tender period upto which you can tender shares in zerodha. Also read below link info in zerodha
3.8. Suneel     Link|Jan 7, 2022 3:16:32 PM
Thanks Lokes and KSRK sir,
Today bought 20 shares at 2223. Thought of buying remaining 60 on Monday. However, shares went up 2285.

Anyhow let's see if I will get opportunity to buy more on Monday
2. helloo     Link|Jan 5, 2022 7:19:29 PM
if someone holding single share on record date then that will be accepted or not here in buyback? how to know that?
1. KAMMA SIVA RAMA KRISHNA     Link|Dec 31, 2021 5:37:05 PM
Nucleus Software buyback page is missing. Please check up and do the needful. Thank you.